Further subgroup analyses confirmed that UNC5B expression was upregulated in breast cancer tissues consistently, regardless of histological subtypes and other clinicopathological features, including gender, race, menopause status, molecular subtype, and cancer stage. This evidence concerns the gene UNC5B and cancer.